Skip to main content

Advertisement

Fig. 2 | Clinical Proteomics

Fig. 2

From: Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA

Fig. 2

The correlation of serum levels of fucosylated PSA–AAL and fucosylated PSA–LCA with tumor Gleason scores. Serum fucosylated PSA after AAL selection with tumor Gleason scores are shown in (a, c). Serum fucosylated PSA after LCA selection with tumor Gleason scores are shown in (b, d). The lines indicate median values in each group

Back to article page